Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes—Protocol 3 with high dose) – (Eye 29, 1538 (December 2015))

10 December 2015

This news item is available to RCOphth members only, please log in below to access.